Adjuvant Topical Chemotherapy versus Immunotherapy in Primary Superficial Transitional Cell Carcinoma of the Bladder
- 1 January 1991
- journal article
- clinical trial
- Published by Wiley in British Journal of Urology
- Vol. 67 (1) , 70-73
- https://doi.org/10.1111/j.1464-410x.1991.tb15072.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Immunotherapy in Bladder Cancer with Keyhole-Limpet Hemocyanin: A Randomized StudyJournal of Urology, 1988
- Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection AloneJournal of Urology, 1984
- Prognostic Factors in Superficial Bladder Tumors. A Study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative GroupJournal of Urology, 1983
- Bladder Cancer ImmunotherapyJournal of Urology, 1982
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Ta and T1 Bladder Cancer: Location, Recurrence and Progression†British Journal of Urology, 1982
- Prognostic Parameters in Superficial Bladder Cancer: An Analysis of 315 CasesJournal of Urology, 1982
- Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinomaUrological Research, 1981
- Epodyl in management of noninvasive vesical neoplasmsUrology, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958